Questions? Call 800-624-6242
add to cart
Rights & Permissions
. "Appendix F: Upjohn Consent to Disclosure." Halcion: An Independent Assessment of Safety and Efficacy Data. Washington, DC: The National Academies Press, 1997.
Please select a format:
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
The medical literature cited in the task force report
Transcripts and minutes of the three advisory committee meetings on the drug
FDA's Biopharmaceutic reviews of the NDA
We understand that physicians' and patients' names will not be disclosed to the public.
Kenneth F. King, Ph.D.
Vice President, Regulatory Affairs
Pharmacia & Upjohn Company